Leah Brandstein
Source: Oxford University
Published: December 2, 2014
Source: Oxford University
Published: December 2, 2014
Summary:
This article details an Oxford University study on effects of antiretroviral therapy (ART) and presence of the gene
HLA-B*57 on HIV. HIV rapidly evolves, thus developing resistance to human’s
natural immunity, but this resistance slows HIVs ability to cause AIDS. Research
on this topic was done with over two thousand women with chronic HIV in Botswana
and South Africa. There is a protein in
human blood called human leukocyte antigen (HLA) that allows the body to differentiate
between proteins of the human body and proteins of pathogens. Specifically, there
is a gene called HLA-B*57, a kind of HLA protein, which helps protect against
HIV, slowing the progress of AIDS. Where HIV has adapted to HLA-B*57, the gene
is no longer beneficial. However, this adaptation significantly lowers the
virus’s virulence and ability to replicate. Regarding the effects of ART on HIV
virulence, the research suggests that when ART is given to combat more virulent
HIV, the HIV evolves but is weakened in its ability to replicate. In conclusion,
'HIV adaptation to the most effective immune responses we can make
against it comes at a significant cost to its ability to replicate,' -lead
scientist Professor Phillip Goulder, University of Oxford.
Connection: This article
relates to what we have been learning in biology in several ways. We are
currently learning about evolution and adaptations in chapter fourteen. Here
the HIV had to adapt to survive in various environments. The HIV which was best
suited to the environment would survive and replicate. Although in adapting the
HIVs ability to replicate was lowered, this adaptation was necessary to best survive
under these conditions. Then, in chapter eleven, we learned about viruses. “A
virus is a package of nucleic acid wrapped in a protein coat,” and viruses can
only reproduce by infecting living cells with their genetic material. HIV or human
immunodeficiency virus is a kind of virus which causes acquired
immunodeficiency syndrome (AIDS). Lastly, this article talks about the HLA-B*57
gene, which helps slow the progression of AIDS. However, not all people
infected with HIV have this gene. This connects to what we learned in chapter
ten, about inheritance following rules of chance and about genetic diversity existing
within a species; thus, not everyone has the exact same form of the HLA protein
present.
If most people have varying forms of the HLA protein, then does an altered form give a different effect?
ReplyDeleteHow does HLA-57 slow HIV?
ReplyDeleteIn response to Jason Lei's question: Yes, there are many different forms of HLA which have different effects. A form of HLA which has similar effects as HLA-B*57 is HLA-B*81. Then within the subgroups of HLA there are subgroups with slightly different effects. For example, a subset of the HLA-B*57 protein is HLA-B*57:03 which has a particularly low viral load. Additionally, different forms of HLA are more common than others.
ReplyDelete